The Single-Domain Antibody Platforms Market in the US is expanding as pharmaceutical and biotechnology companies increasingly utilize compact antibody formats for therapeutic development, diagnostics, drug discovery, and biomedical research. Single-domain antibodies, including nanobodies and VHH-based formats, are being explored for their small molecular size, target-bindin Market...